Infliximab Heavy chain (46-60)

Ref. 3D-CRB1001519

Informations sur le produit

• Nom: Infliximab Heavy chain (46-60)
• Synonymes: H-EWVAEIRSKSINSAT-OH

Description

Infliximab is a biologic medicine used in the treatment of numerous autoimmune diseases including Crohn disease, rheumatoid arthritis, and ankylosing spondylitis. Infliximab binds with high affinity to tumour necrosis factor-α (TNF-α) blocking most of the cytokine effects, which includes mediating the inflammatory responses. Infliximab is a chimeric human-mouse IgG monoclonal antibody- the constant regions of the heavy and light chains are human-derived. The heavy chain peptide (46-60) has been identified as an antigen for antigen-specific T cell analysis. Numerous methods of immunological analysis can be applied to this peptide to hopefully provide further insight to these autoimmune conditions.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,689.9 g/mol